caffeine has been researched along with alvocidib in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Johnson, LN; Oikonomakos, NG; Schnier, JB; Skamnaki, VT; Tsitsanou, KE; Zographos, SE | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Krimm, I; Lancelin, JM; Praly, JP | 1 |
Bradbury, EM; Gorin, FA; Kaiser, A; Nishi, K; Schnier, JB; Walsh, DA | 1 |
Bischler, N; Chrysina, ED; Eisenbrand, G; Kosmopoulou, MN; Leonidas, DD; Oikonomakos, NG; Pauptit, R; Sakarellos, CE | 1 |
6 other study(ies) available for caffeine and alvocidib
Article | Year |
---|---|
Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site.
Topics: Animals; Binding Sites; Caffeine; Flavonoids; Glucose; Kinetics; Models, Molecular; Muscle, Skeletal; Phosphorylases; Piperidines; Protein Conformation; Rabbits | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Binding evaluation of fragment-based scaffolds for probing allosteric enzymes.
Topics: Allosteric Regulation; Binding Sites; Enzyme Inhibitors; Glycogen Phosphorylase; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Protein Binding; Structure-Activity Relationship | 2012 |
The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase.
Topics: Adenosine Monophosphate; Amino Acid Sequence; Animals; Brain; Caffeine; Calmodulin-Binding Proteins; Cyclin-Dependent Kinases; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Glycogen; HeLa Cells; Humans; Isoenzymes; Liver; Molecular Sequence Data; Muscle, Skeletal; Nerve Tissue Proteins; Neurogranin; Peptide Fragments; Phosphorylases; Phosphorylation; Piperidines; Protein Binding; Rabbits; Tumor Cells, Cultured | 2001 |
Binding of the potential antitumour agent indirubin-5-sulphonate at the inhibitor site of rabbit muscle glycogen phosphorylase b. Comparison with ligand binding to pCDK2-cyclin A complex.
Topics: Animals; Antineoplastic Agents; Binding Sites; Caffeine; CDC2-CDC28 Kinases; Cyclin A; Cyclin-Dependent Kinase 2; Enzyme Inhibitors; Flavonoids; Glucose; Glycogen Phosphorylase, Muscle Form; Indoles; Ligands; Macromolecular Substances; Models, Molecular; Muscles; Piperidines; Rabbits; Sulfonic Acids | 2004 |